Showing 1,161 - 1,180 results of 6,525 for search '"cardiovascular"', query time: 0.11s Refine Results
  1. 1161
  2. 1162

    Interactions of ST-elevation myocardial infarction, age, and sex and the risk of major adverse cardiovascular events among Chinese adults: a secondary analysis of a single-centre prospective cohort by Lin Zhou, Wei Yuan, Cuiping Wang, Yi Liang, Peijing Liu

    Published 2022-07-01
    “…A total of 843 adults were included in the analysis.Primary and secondary outcome measures MACE was defined as any occurrence of cardiovascular mortality, MI recurrence, cardiogenic shock or heart failure. …”
    Get full text
    Article
  3. 1163

    NT-proBNP and Major Adverse Cardiovascular Events in Patients with ST-Segment Elevation Myocardial Infarction Who Received Primary Percutaneous Coronary Intervention: A Prospective Cohort Study by Zuoan Qin, Yaoyao Du, Quan Zhou, Xuelin Lu, Li Luo, Zhixiang Zhang, Ning Guo, Liangqing Ge

    Published 2021-01-01
    “…The prognostic significance of the amino-terminal fragment of the prohormone brain-type natriuretic peptide (NT-proBNP) in patients with ST-segment elevation myocardial infarction (STEMI) after percutaneous coronary intervention (PCI) has not been fully elucidated. Major adverse cardiovascular events (MACEs) are clinically viable indicators for the accurate, rapid, and safe evaluation of patients with STEMI. …”
    Get full text
    Article
  4. 1164
  5. 1165

    Emergent Biomarkers of Residual Cardiovascular Risk in Patients with Low HDL-c and/or High Triglycerides and Average LDL-c Concentrations: Focus on HDL Subpopulations, Oxidized LDL, Adiponectin, and Uric Acid by Filipa Mascarenhas-Melo, Filipe Palavra, Daniela Marado, José Sereno, Edite Teixeira-Lemos, Isabel Freitas, Maria Isabel-Mendonça, Rui Pinto, Frederico Teixeira, Flávio Reis

    Published 2013-01-01
    “…This study intended to determine the impact of HDL-c and/or TGs levels on patients with average LDL-c concentration, focusing on lipidic, oxidative, inflammatory, and angiogenic profiles. Patients with cardiovascular risk factors (n=169) were divided into 4 subgroups, combining normal and low HDL-c with normal and high TGs patients. …”
    Get full text
    Article
  6. 1166
  7. 1167

    Utility of measurement of left ventricular global longitudinal strain by two-dimensional speckle-tracking echocardiography to predict cardiovascular events in patients with left ventricular systolic dysfunction: A pilot study by Susheel Kumar Malani, Digvijay Nalawade, Sridevi Chigulapalli, Shubhangi Kanitkar, Ajitkumar Jadhav, Madhura Gandhi

    Published 2024-12-01
    “…Echocardiographic data, including LV-GLS, LVEF, and WMSI, were collected, alongside monitoring for cardiovascular events such as heart failure hospitalizations, cardiac mortality, and all-cause mortality. …”
    Get full text
    Article
  8. 1168
  9. 1169

    Time in Range, as a Novel Metric of Glycemic Control, Is Reversely Associated with Presence of Diabetic Cardiovascular Autonomic Neuropathy Independent of HbA1c in Chinese Type 2 Diabetes by Qingyu Guo, Pu Zang, Shaoying Xu, Wenjing Song, Zhen Zhang, Chunyan Liu, Zhanhong Guo, Jing Chen, Bin Lu, Ping Gu, Jiaqing Shao

    Published 2020-01-01
    “…The objective of this study is to investigate the relationship between time in range (TIR), a new metric of continuous glucose monitoring (CGM) and cardiovascular autonomic neuropathy (CAN) in individuals with type 2 diabetes mellitus (T2DM). …”
    Get full text
    Article
  10. 1170
  11. 1171
  12. 1172
  13. 1173
  14. 1174

    Association of frailty with non-laboratory based cardiovascular disease risk score among older adults and elderly population: insights from longitudinal aging study in India (LASI-1st wave) by Pritam Halder, Semanti Das, Anshul Mamgai, Divya Sharma, Ashish Behera, Pulak Syal, Vineeth Rajagopal, Tanvi Kiran

    Published 2025-01-01
    “…Abstract Introduction Frailty is an inevitable part of ageing, which is also associated with a variety of chronic diseases, the most common of which are cardiovascular diseases. The WHO non-laboratory-based CVD risk scores are reliable predictors of cardiovascular events and are used in treatment decision-making in primary health-care settings. …”
    Get full text
    Article
  15. 1175
  16. 1176

    Strategies to Improve Health Care Provider Prescription of and Patient Adherence to Guideline-Recommended Cardiovascular Medications for Atherosclerotic Occlusive Disease: Protocol for Two Systematic Reviews and Meta-Analyses of Randomized Controlled Trials by Aidan M Kirkham, Dean A Fergusson, Justin Presseau, Daniel I McIsaac, Risa Shorr, Derek J Roberts

    Published 2025-01-01
    “…ObjectiveWe aim to systematically review and meta-analyze RCTs examining the effectiveness of implementation or adherence-supporting strategies for improving health care provider prescription of, or patient adherence to, guideline-recommended cardiovascular medications in patients with atherosclerotic occlusive disease. …”
    Get full text
    Article
  17. 1177
  18. 1178
  19. 1179
  20. 1180

    Examining the impact of a community-based exercise intervention on cardiorespiratory fitness, cardiovascular health, strength, flexibility and physical activity among adults living with HIV: A three-phased intervention study. by Kelly K O'Brien, Aileen M Davis, Soo Chan Carusone, Lisa Avery, Ada Tang, Patricia Solomon, Rachel Aubry, Mehdi Zobeiry, Ivan Ilic, Zoran Pandovski, Ahmed M Bayoumi

    Published 2021-01-01
    “…<h4>Purpose</h4>Our aim was to examine the impact of a community-based exercise (CBE) intervention on cardiorespiratory fitness, cardiovascular health, strength, flexibility, and physical activity outcomes among adults living with HIV.…”
    Get full text
    Article